QIAGEN Builds on Global Collaboration With Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer

QIAGEN and Amgen to develop tissue-based therascreen test, paired with investigational treatment AMG 510, to identify patients whose cancers have KRAS G12C mutation QIAGEN to pursue global regulat...